About NovaBay Pharmaceuticals, Inc. Common Stock (NBY)
NovaBay Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative products for the eye care and dermatology markets. The company leverages its proprietary technology platform to create and market treatments that address unmet medical needs, primarily targeting infections and conditions that affect skin and eye health. NovaBay's product pipeline includes a range of topical antimicrobial and anti-inflammatory solutions, aiming to provide effective and safe alternatives for patients and healthcare professionals. Through its commitment to research and development, NovaBay seeks to enhance the quality of care and improve patient outcomes in various therapeutic areas. Read More
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market session. The company's market cap stands at $2.2 million.
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Looking for insights into the US markets one hour before the close of the markets on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
